Physical, emotional, and practical symptom burden in patients with terminal illnesses
Charles B. Simone II
DOI: https://doi.org/10.21037/apm-24-103
2024-07-26
Annals of Palliative Medicine
Abstract:Charles B. Simone II New York Proton Center, New York, NY, USA Submitted Jul 15, 2024. Accepted for publication Jul 16, 2024. Published online Jul 22, 2024. doi: 10.21037/apm-24-103 The May 2024 issue of Annals of Palliative Medicine featured 4 Original Articles, 14 Review Articles, 1 Editorial, 3 Editorial Commentary Articles, and 1 Expert Consensus. One of the Original Articles focusing on symptom burden in terminally ill patients by Fordjour and colleagues from The University of Hong Kong (1) will be featured in this Message From the Editor-in-Chief. Patients with end-stage disease in the final months of their lives often experience a high symptom burden (2,3). Beyond their suffering from physical symptoms, terminal illnesses can often affect physiological, psychosocial and spiritual wellness of patients and their families (4). Furthermore, it has been well described that terminally ill patients often die with unmet needs (5,6), underscoring the importance of characterizing these needs in order to be able to better address them. End of life care can best be optimized by understanding the scope of symptom burden that patients face with end-stage diseases. As this symptom burden differs for different terminal conditions—from cancer to heart disease to neurological or kidney or pulmonary diseases, for example—it is critical to understand the symptoms and overall holistic effects that each diseases places on patients. Such an understanding can effectively be performed through quantified symptom assessment scores, including through the use of patient-reported outcome measurements (7). The Integrated Palliative care Outcome Scale (IPOS) is a widely used and validated patient-reported tool consisting of 17 items (10 measuring physical symptoms, 4 measuring emotional symptoms, and 3 measuring communication/practical issues) rated on a 5-point Likert scale. The IPOS tool can provide for a comprehensive assessment of the factors contributing to various categories of symptom burdens in terminally ill patients, and it provides a total IPOS score, as well as subscale scores for physical symptoms, emotional symptoms, and communication and practical issues (8). While such assessments with IPOS often have been conducted in patients with end-stage malignancies and heart failure, little quantitative data exist for other terminal diseases. Therefore, Fordjour and colleagues (1) attempted to significantly add to the understanding of symptom burden in other terminal conditions by administering IPOS to a diversity of patients with terminal illnesses to provide a comprehensive analysis of the perceived symptom burden intensity across patients with a variety of end-stage diseases and to assess the influence that patient demographics and clinical factors have on their perceived symptom burden intensity. Specifically, Fordjour et al. (1) asked " what are the major distressing symptoms reported by the overall terminally ill patients, cancer and non-cancer patients ... are there differences in perceived symptom burden intensity across diverse patient disease groups ... and what are the demographics and clinical factors influencing the perceived intensity of symptom burden in terms of the IPOS total and subscale scores among terminally-ill patients? ". They assessed patients with a prognosis of less than 12 months treated within their End of Life Care service model in Hong Kong between January 2016 and December 2021 using the IPOS tool evaluation at baseline, one month after service and 3 months after service. Among 1,998 patients who consented to participate in the study, 354 could not complete the baseline questionnaire and 95 had incomplete or missing data, leaving a cohort of 1,549 terminally ill patients assessed. Approximately half of those patients were 80 years of age or older (48.7%), and the cohort had a slight male predominance (53.1%). Patients most commonly had cancer (53.4%), end-stage renal disease (19.2%), chronic obstructive pulmonary disease (8.3%), motor neuron disease (4.3%), Parkinson's disease (3.5%), heart failure (3.4%), or dementia (2.7%). The most distressing symptom reported by the overall cohort was poor mobility, followed in order by perceived family anxiety, inability to share feelings, weakness/lack of energy, and hardly feeling at peace. Notably, all 4 of the emotional symptom questions and all 3 of the communication/practical issue questions from the IPOS tool were ranked among the 11 most distressing symptoms, whereas only 4 of the 10 physical symptom questions (poor mobility #1, weakness/lack of energy #4, drowsiness #6, and pain #10) were in the top 11 most distressing symptoms. Fordjour and colleagues (1) identified some important differences across terminal conditions, with non-cancer patients being more likely to rank poor mobility as the most distressing symptom. In fact, perceived family anxiety was the most distressing s -Abstract Truncated-
health care sciences & services